PANACEA BIOTEC Financial Statement Analysis
|
||
|
The Revenues of PANACEA BIOTEC have decreased by -30.44% YoY .
The Earnings Per Share (EPS) of PANACEA BIOTEC has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PANACEA BIOTEC Last 5 Annual Financial Results
[BOM: 531349|NSE : PANACEABIO]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹460 Cr | ₹661 Cr | ₹625 Cr | ₹544 Cr | ₹457 Cr |
| Expenses | ₹558 Cr | ₹674 Cr | ₹548 Cr | ₹519 Cr | ₹590 Cr |
| Operating Profit (Excl OI) | ₹-98 Cr | ₹-13 Cr | ₹77 Cr | ₹25 Cr | ₹-133 Cr |
| Other Income | ₹52 Cr | ₹11 Cr | ₹9.98 Cr | ₹30 Cr | ₹5.06 Cr |
| Interest | ₹4.44 Cr | ₹181 Cr | ₹185 Cr | ₹174 Cr | ₹105 Cr |
| Depreciation | ₹39 Cr | ₹44 Cr | ₹46 Cr | ₹44 Cr | ₹55 Cr |
| Profit Before Tax | ₹13 Cr | ₹1,449 Cr | ₹-144 Cr | ₹-178 Cr | ₹46 Cr |
| Profit After Tax | ₹-34 Cr | ₹1,078 Cr | ₹-146 Cr | ₹-195 Cr | ₹38 Cr |
| Consolidated Net Profit | ₹-33 Cr | ₹1,078 Cr | ₹-148 Cr | ₹-194 Cr | ₹38 Cr |
| Earnings Per Share (Rs) | ₹-5.43 | ₹176.05 | ₹-24.11 | ₹-31.72 | ₹6.16 |
| PAT Margin (%) | -7.12 | 155.09 | -22.32 | -35.77 | 8.22 |
| ROE(%) | -3.92 | 332.85 | 0.00 | -75.26 | 11.39 |
| ROCE(%) | 1.94 | 217.12 | 5.36 | -0.38 | 13.44 |
| Total Debt/Equity(x) | 0.02 | 0.04 | -3.58 | 4.45 | 1.85 |
Key Financials |
||
| Market Cap | : | ₹ 842.0 Cr |
| Revenue (TTM) | : | ₹ 551.6 Cr |
| Net Profit(TTM) | : | ₹ -12.2 Cr |
| EPS (TTM) | : | ₹ -2.0 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PANACEA BIOTEC | -6.4% | -21.9% | 18.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
PANACEA BIOTEC Revenues
[BOM: 531349|NSE : PANACEABIO]
| Y-o-Y | -30.44 % |
| 5 Yr CAGR | 0.18 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹460 Cr | -30.44 | |
| Mar2022 | ₹661 Cr | 5.83 | |
| Mar2021 | ₹625 Cr | 14.84 | |
| Mar2020 | ₹544 Cr | 19.13 | |
| Mar2019 | ₹457 Cr | - | |
PANACEA BIOTEC Operating Profit
[BOM: 531349|NSE : PANACEABIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹-98 Cr | Negative | |
| Mar2022 | ₹-13 Cr | Negative | |
| Mar2021 | ₹77 Cr | 200.65 | |
| Mar2020 | ₹25 Cr | Positive | |
| Mar2019 | ₹-133 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | -21.3% | Negative | |
| Mar2022 | -2% | Negative | |
| Mar2021 | 12.26% | 161.97 | |
| Mar2020 | 4.68% | Positive | |
| Mar2019 | -29.15% | - | |
PANACEA BIOTEC Profit After Tax
[BOM: 531349|NSE : PANACEABIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹1,078 Cr | Positive | |
| Mar2021 | ₹-148 Cr | Negative | |
| Mar2020 | ₹-194 Cr | Negative | |
| Mar2019 | ₹38 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | -7.12 % | Negative | |
| Mar2022 | 155.09 % | Positive | |
| Mar2021 | -22.32 % | Negative | |
| Mar2020 | -35.77 % | Negative | |
| Mar2019 | 8.22 % | - | |
PANACEA BIOTEC Earnings Per Share (EPS)
[BOM: 531349|NSE : PANACEABIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹-5.43 | Negative | |
| Mar2022 | ₹176 | Positive | |
| Mar2021 | ₹-24 | Negative | |
| Mar2020 | ₹-32 | Negative | |
| Mar2019 | ₹6.16 | - | |
PANACEA BIOTEC Return on Capital Employed (ROCE)
[BOM: 531349|NSE : PANACEABIO]
| Y-o-Y | -99.11 % |
| 5 Yr CAGR | -38.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 1.94% | -99.11 | |
| Mar2022 | 217.12% | 3,950.75 | |
| Mar2021 | 5.36% | Positive | |
| Mar2020 | -0.38% | Negative | |
| Mar2019 | 13.44% | - | |
PANACEA BIOTEC Share Price vs Sensex
| Current Share Price | : | ₹137.4 |
| Current MarketCap | : | ₹ 842.0 Cr |
| Updated EOD on | : | Apr 18,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -6.4% |
-21.9% |
18.8% |
| SENSEX | -2.9% |
-0.4% |
20% |
PANACEA BIOTEC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
| S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
| S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
| S&P BSE HEALTHCARE | -3.1% | 2.5% | 51.1% |
No NSE index found
You may also like the below Video Courses
FAQ about PANACEA BIOTEC Financials
How the annual revenues of PANACEA BIOTEC have changed ?
The Revenues of PANACEA BIOTEC have decreased by -30.44% YoY .
How the Earnings per Share (EPS) of PANACEA BIOTEC have changed?
The Earnings Per Share (EPS) of PANACEA BIOTEC has decreased by Negative YoY .
Check out Intrinsic Value of Peers of PANACEA BIOTEC
Compare Stock Analytics of Peers of PANACEA BIOTEC
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
